News Releases

Anixa Biosciences to Present at Biotech Showcase 2024

December 14, 2023

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

December 6, 2023

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

December 6, 2023

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

November 27, 2023

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

October 31, 2023

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

October 23, 2023

Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial

October 13, 2023

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

October 3, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

September 19, 2023

Anixa Biosciences to Participate in September Investor Conferences

August 31, 2023

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...

Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...

Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...